These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35986031)

  • 21. Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.
    Grahn A; Hagberg L; Nilsson S; Blennow K; Zetterberg H; Studahl M
    J Neurol; 2013 Jul; 260(7):1813-21. PubMed ID: 23471614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
    Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
    J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective.
    Arslan B; Ayhan Arslan G; Tuncer A; Karabudak R; Sepici Dinçel A
    Bosn J Basic Med Sci; 2022 Sep; 22(5):699-706. PubMed ID: 35490364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adults with suspected central nervous system infection: A prospective study of diagnostic accuracy.
    Khatib U; van de Beek D; Lees JA; Brouwer MC
    J Infect; 2017 Jan; 74(1):1-9. PubMed ID: 27746160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.
    Alirezaei Z; Pourhanifeh MH; Borran S; Nejati M; Mirzaei H; Hamblin MR
    Mol Neurobiol; 2020 Jan; 57(1):469-491. PubMed ID: 31385229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofilament light chain as a biomarker in neurological disorders.
    Gaetani L; Blennow K; Calabresi P; Di Filippo M; Parnetti L; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):870-881. PubMed ID: 30967444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis.
    Nylén K; Karlsson JE; Blomstrand C; Tarkowski A; Trysberg E; Rosengren LE
    J Neurosci Res; 2002 Mar; 67(6):844-51. PubMed ID: 11891800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated plasma neurofilament light chain in immune-mediated neurological disorders (IMND) detected by immunomagnetic reduction (IMR).
    Huang KY; Wu CL; Chang YS; Huang WY; Su FC; Lin SW; Chien YY; Weng WC; Wei YC
    Brain Res; 2023 Dec; 1821():148587. PubMed ID: 37739331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie.
    Betancor M; Pérez-Lázaro S; Otero A; Marín B; Martín-Burriel I; Blennow K; Badiola JJ; Zetterberg H; Bolea R
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis.
    Abdelhak A; Barba L; Romoli M; Benkert P; Conversi F; D'Anna L; Masvekar RR; Bielekova B; Prudencio M; Petrucelli L; Meschia JF; Erben Y; Furlan R; De Lorenzo R; Mandelli A; Sutter R; Hert L; Epple V; Marastoni D; Sellner J; Steinacker P; Aamodt AH; Heggelund L; Dyrhol-Riise AM; Virhammar J; Fällmar D; Rostami E; Kumlien E; Blennow K; Zetterberg H; Tumani H; Sacco S; Green AJ; Otto M; Kuhle J; Ornello R; Foschi M; Abu-Rumeileh S
    J Neurol; 2023 Jul; 270(7):3315-3328. PubMed ID: 37184659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.
    Boesen MS; Jensen PEH; Magyari M; Born AP; Uldall PV; Blinkenberg M; Sellebjerg F
    Mult Scler Relat Disord; 2018 Aug; 24():175-183. PubMed ID: 30055504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.
    Mariotto S; Farinazzo A; Magliozzi R; Alberti D; Monaco S; Ferrari S
    J Peripher Nerv Syst; 2018 Sep; 23(3):174-177. PubMed ID: 29974556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
    Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
    AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.
    Yilmaz A; Blennow K; Hagberg L; Nilsson S; Price RW; Schouten J; Spudich S; Underwood J; Zetterberg H; Gisslén M
    Expert Rev Mol Diagn; 2017 Aug; 17(8):761-770. PubMed ID: 28598205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders.
    Kang MJY; Eratne D; Dobson H; Malpas CB; Keem M; Lewis C; Grewal J; Tsoukra V; Dang C; Mocellin R; Kalincik T; Santillo AF; Zetterberg H; Blennow K; Stehmann C; Varghese S; Li QX; Masters CL; Collins S; Berkovic SF; Evans A; Kelso W; Farrand S; Loi SM; Walterfang M; Velakoulis D
    Acta Neuropsychiatr; 2024 Feb; 36(1):17-28. PubMed ID: 37114460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.